Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | PTPRF | P10586 | 1/20 | 0.59 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.59 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.57 |
| ▸ | LTA4H | P09960 | 1/20 | 0.56 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.56 |
| ▸ | CRHBP | P24387 | 3/20 | 0.56 |
| ▸ | CRHR2 | Q13324 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL30096531 | 0.94 | ALDH1A1 (0.64) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL8087428 | 0.91 | POLB (0.76) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL8094050 | 0.91 | POLB (0.76) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL44366 | 0.91 | POLB (0.76) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL13946243 | 0.87 | CYP1A2 (0.67) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL27583120 | 0.84 | ALDH1A1 (0.65) | ALDH1A1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL8094543 | 0.84 | POLB (0.68) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL10651848 | 0.84 | TSHR (0.62) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| Diphenylmethane SCHEMBL9099577 | 0.84 | CA2 (0.54) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| Bromide SCHEMBL8664123 | 0.83 | MEN1 (0.94) | ALDH1A1MEN1KMT2AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110668950-B | Chiral delta-nitroketene compound and asymmetric synthesis method and application thereof | 浙江工业大学 | 2023-03-31 | — | — | CN | claimed |
| CN-110668950-A | Chiral delta-nitroketene compound and asymmetric synthesis method and application thereof | 浙江工业大学 | 2020-01-10 | — | — | CN | claimed |
| CN-109759109-A | The preparation and the application in nitrobenzene compounds hydrogenation reaction that nitrogen modifies charcoal supported noble metal hydrogenation catalyst | 浙江工业大学 | 2019-05-17 | — | — | CN | claimed |
| EP-2905272-B1 | Process for hydrogenating aromatic di- and polyamines to cycloaliphatic di- and polyamines | COVESTRO DEUTSCHLAND AG (DE) | 2016-11-23 | — | — | EP | claimed |
| US-9278906-B2 | Process for hydrogenating aromatic di- and polyamines to cycloaliphatic di- and polyamines | BAYER MATERIALSCIENCE AG (DE) | 2016-03-08 | — | — | US | claimed |
| EP-2905272-A1 | Process for hydrogenating aromatic di- and polyamines to cycloaliphatic di- and polyamines | Bayer MaterialScience AG (DE) | 2015-08-12 | — | — | EP | claimed |
| US-20150218083-A1 | PROCESS FOR HYDROGENATING AROMATIC DI- AND POLYAMINES TO CYCLOALIPHATIC DI- AND POLYAMINES | COVESTRO DEUTSCHLAND AG (DE) | 2015-08-06 | — | — | US | claimed |
| CN-104817459-A | Process for hydrogenating aromatic di- and polyamines to cycloaliphatic di- and polyamines | BAYER MATERIALSCIENCE AG | 2015-08-05 | — | — | CN | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| CN-101304973-A | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORP (CA) | 2008-11-12 | — | — | CN | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| EP-4131548-B1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | MITSUI CHEMICALS INC (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-11767297-B2 | Compounds for inhibiting TNIK and medical uses thereof | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-09-26 | — | — | US | disclosed |
| CN-113943199-B | Method for synthesizing amide compound by using nitrile and diaryl methane as raw materials | 浙江工业大学 | 2023-09-22 | — | — | CN | disclosed |
| US-20230110251-A1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | MITSUI CHEMICALS, INC. (JP) | 2023-04-13 | — | — | US | disclosed |
| EP-0103990-A1 | Process for making diarylamines | UNIROYAL, INC. (US) | 1984-03-28 | — | — | EP | disclosed |
| US-4431841-A | REACTING PRIMARY AROMATIC AMINES AND ALICYCLIC KETONES USING AN ACID PROMOTER AND A PLATINUM CATALYST | UNIROYAL, INC. (US) | 1984-02-14 | — | — | US | disclosed |
| EP-0078709-A2 | Preparation of nitroaralkyl cyanides and derivatives thereof | ETHYL CORPORATION (US) | 1983-05-11 | — | — | EP | disclosed |
| EP-0040408-A1 | Beta-lactam compounds and process for production thereof | SANRAKU-OCEAN CO., LTD. (JP) | 1981-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150218083-A1 | PROCESS FOR HYDROGENATING AROMATIC DI- AND POLYAMINES TO CYCLOALIPHATIC DI- AND POLYAMINES | DDT, HRH3, HRH4 | ALDH1A1 4474/4885MEN1 1146/4885KMT2A 884/4885 |
| US-11767297-B2 | Compounds for inhibiting TNIK and medical uses thereof | TNNI3K, TNK1, TNIK | ALDH1A1 4519/4885MEN1 2818/4885KMT2A 2586/4885 |
| US-20230110251-A1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | PHOSPHO1, SLC9B2, SLC9A2 | ALDH1A1 3982/4885MEN1 1085/4885KMT2A 472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.